DDDelphine Demede

Delphine Demede

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Delphine Demede has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Valeska Bidault-Jourdainne

    Service de Chirurgie Uro-Viscérale et Thoracique Pédiatrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France; Centre de référence MARVU, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France; INSERM U1208 Stem Cell and Brain Research Institute (SBRI), Université Claude Bernard Lyon 1, Bron, France

    3 shared publications
  • Berenice Tulelli

    Service de Chirurgie Uro-Viscérale et Thoracique Pédiatrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France; Centre de référence MARVU, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France; Université Claude Bernard Lyon 1, Lyon, France

    2 shared publications
  • A. Fichez

    Service de Gynécologie-Obstétrique, Service de Diagnostic Anténatal, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France

    1 shared publication
  • Aurore Bouty

    The Royal Children’s Hospital

    1 shared publication
  • Aurélien Scalabre

    Pediatric Surgery Unit, CHU de Saint Etienne, Saint. Etienne, France

    1 shared publication
  • Axel Fichez

    Multidisciplinary Center for Prenatal Diagnosis (CPDPN), Hôpital de la Croix-Rousse , 69000 Lyon

    1 shared publication

Latest Publications

  • Open Access

    Prenatal care for disorders/differences of sex development: 10 years look back in an expert center

    by Julie Carion, Valeska Bidault Jourdainne, Jérôme Massardier, Carine Abel, Mona Massoud, Axel Fichez, Delphine Demede, Delphine Mallet, Ingrid Plotton, Patricia Bretones

    Context: Phenotypic presentations and etiologies of disorders/differences of sex development (DSD) are variable. While postnatal management is well described, no consensus exists regarding prenatal care, despite increasingly frequent detection. Objective: To describe prenatal management practices of isolated ultrasound suspicion of DSD referred to the Multidisciplinary Center for Prenatal Diagnosis (MCPD) of Lyon over a 10-year period. Methods: Retrospective study of pregnancies referred to MCPD between January 2013 and December 2022 for isolated ultrasound suspicion of DSD. Fetuses referred for family history risk were not included. DSD were considered isolated when no additional malformation was suspected at referral, except minor cardiac anomalies, renal pelvis or ureteral dilation, and intrauterine growth restriction (IUGR). Results: Of 71 patients referred for suspected isolated DSD, 57 were confirmed by experts. At birth, 52.3% newborn were preterm and 52.3% had IUGR. Among the 57 prenatally suspicion, 41 children presented a DSD phenotype. SRY testing on maternal blood was performed in 17.5% of cases and invasive examination was performed in 59.6% of cases. Amniotic fluid analyses included steroid profile (76.5%), biochemical analyses for Smith-Lemli-Opitz (SLO) syndrome (64.7%), and genetic analyses (100%). Genetic analyses comprised karyotype (100%), comparative genomic hybridization array (67.6%), DSD panel (14.7%), targeted gene analysis (35.3%). A molecular diagnosis was obtained in 13 cases, including 5 prenatally. Three fetuses were ultimately diagnosed with severe neurological conditions. Conclusion: Prenatal assessment may support counseling and care planning for families expecting a child with DSD. Further prospective studies are necessary to confirm these findings and formulate recommendations for prenatal management of DSD.

  • Open Access

    Prenatal and postnatal outcomes of foetal megacystis: What to expect when posterior urethral valves are excluded? A retrospective multicentre study

    by C. Rochet-Capellan, B. Tulelli, J. Massardier, A. Fichez, M. Massoud, J. Teoli, D. Demède, V. Bidault


  • Open Access

    Paediatric robotic surgery simulation: Results of a national survey and scoping review

    by Berenice Tulelli, Emanuela Gallo, Delphine Demede, Rémi Dubois, Valeska Bidault, Frédéric Hameury

  • Open Access

    Early detection of ureteropelvic junction obstruction in neonates with prenatal diagnosis of renal pelvis dilatation using 1H NMR urinary metabolomics

    by Aurélien Scalabre, Yohann Clément, Florence Guillière, Sophie Ayciriex, Ségolène Gaillard, Delphine Demède, Aurore Bouty, Pierre Lanteri, Pierre-Yves Mure

    Renal pelvis dilatation (RPD) is diagnosed in utero on prenatal ultrasonography (US) and can resolve spontaneously. However, isolated RPD can also reflect ureteropelvic junction obstruction (UPJO), which requires surgical treatment to prevent progressive renal deterioration. The diagnosis of UPJO can only be confirmed after birth with repeat US and renal isotope studies. 1H Nuclear Magnetic Resonance spectroscopy (NMR) was performed on urine of newborns with prenatally diagnosed unilateral RPD and healthy controls to identify specific urinary biomarkers for UPJO. The original combination of EigenMS normalization and sparse partial-least-squares discriminant analysis improved selectivity and sensitivity. In total, 140 urine samples from newborns were processed and 100 metabolites were identified. Correlation network identified discriminant metabolites in lower concentrations in UPJO patients. Two main metabolic pathways appeared to be impaired in patients with UPJO i.e. amino acid and betaine metabolism. In this prospective study, metabolic profiling of urine samples by NMR clearly distinguishes patients who required surgery for UPJO from patients with transient dilatations and controls. This study will pave the way for the use of metabolomics for the diagnosis of prenatal hydronephrosis in clinical routine.